{"id":"https://openalex.org/W2053481663","doi":"https://doi.org/10.1371/journal.pone.0072709","title":"Interferon-\u03b2 Produces Synergistic Combinatory Anti-Tumor Effects with Cisplatin or Pemetrexed on Mesothelioma Cells","display_name":"Interferon-\u03b2 Produces Synergistic Combinatory Anti-Tumor Effects with Cisplatin or Pemetrexed on Mesothelioma Cells","alternate_titles":[],"publication_year":2013,"publication_date":"2013-08-16","ids":{"openalex":"https://openalex.org/W2053481663","doi":"https://doi.org/10.1371/journal.pone.0072709","mag":"2053481663","pmid":"https://pubmed.ncbi.nlm.nih.gov/23977343","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3745385"},"language":"en","primary_location":{"id":"doi:10.1371/journal.pone.0072709","doi":"https://doi.org/10.1371/journal.pone.0072709","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0072709","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0072709&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2053481663"],"child_works_count":8,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0072709&type=printable","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048238301","display_name":"Quanhai Li","orcid":"https://orcid.org/0000-0003-3629-3856","observed_orcids":["https://orcid.org/0000-0003-3629-3856"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]},{"id":"https://openalex.org/I4405286631","display_name":"Chiba Cancer Center Research Institute","ror":"https://ror.org/02p9eh956","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210115246","https://openalex.org/I4405286631"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Quanhai Li","raw_affiliation_strings":["Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan","Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan","institution_ids":["https://openalex.org/I4405286631"]},{"raw_affiliation_string":"Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan","institution_ids":["https://openalex.org/I159385669"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109152171","display_name":"Kiyoko Kawamura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405286631","display_name":"Chiba Cancer Center Research Institute","ror":"https://ror.org/02p9eh956","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210115246","https://openalex.org/I4405286631"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kiyoko Kawamura","raw_affiliation_strings":["Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan","institution_ids":["https://openalex.org/I4405286631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100764375","display_name":"Shan Yang","orcid":"https://orcid.org/0000-0003-3529-841X","observed_orcids":["https://orcid.org/0000-0003-3529-841X"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]},{"id":"https://openalex.org/I4405286631","display_name":"Chiba Cancer Center Research Institute","ror":"https://ror.org/02p9eh956","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210115246","https://openalex.org/I4405286631"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shan Yang","raw_affiliation_strings":["Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan","Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan","institution_ids":["https://openalex.org/I159385669"]},{"raw_affiliation_string":"Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan","institution_ids":["https://openalex.org/I4405286631"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Shinya Okamoto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Shinya Okamoto","raw_affiliation_strings":["Department of Biochemistry, Graduate School of Pharmaceutical Science, Chiba University, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, Graduate School of Pharmaceutical Science, Chiba University, Chiba, Japan","institution_ids":["https://openalex.org/I159385669"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040233451","display_name":"Hiroshi Kobayashi","orcid":"https://orcid.org/0000-0002-8124-6269","observed_orcids":["https://orcid.org/0000-0002-8124-6269"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Kobayashi","raw_affiliation_strings":["Department of Biochemistry, Graduate School of Pharmaceutical Science, Chiba University, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biochemistry, Graduate School of Pharmaceutical Science, Chiba University, Chiba, Japan","institution_ids":["https://openalex.org/I159385669"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101758036","display_name":"Yuji Tada","orcid":"https://orcid.org/0000-0002-6960-3323","observed_orcids":["https://orcid.org/0000-0002-6960-3323"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuji Tada","raw_affiliation_strings":["Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan","institution_ids":["https://openalex.org/I159385669"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060063956","display_name":"Ikuo Sekine","orcid":"https://orcid.org/0000-0003-1105-7339","observed_orcids":["https://orcid.org/0000-0003-1105-7339"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ikuo Sekine","raw_affiliation_strings":["Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan","institution_ids":["https://openalex.org/I159385669"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027580659","display_name":"Yuichi Takiguchi","orcid":"https://orcid.org/0000-0001-6059-7476","observed_orcids":["https://orcid.org/0000-0001-6059-7476"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuichi Takiguchi","raw_affiliation_strings":["Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan","institution_ids":["https://openalex.org/I159385669"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076757214","display_name":"Masato Shingyouji","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210115246","display_name":"Chiba Cancer Center","ror":"https://ror.org/02120t614","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210115246"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masato Shingyouji","raw_affiliation_strings":["Division of Thoracic Diseases, Chiba Cancer Center, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Thoracic Diseases, Chiba Cancer Center, Chiba, Japan","institution_ids":["https://openalex.org/I4210115246"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005005279","display_name":"Koichiro Tatsumi","orcid":"https://orcid.org/0000-0001-9484-7912","observed_orcids":["https://orcid.org/0000-0001-9484-7912"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Koichiro Tatsumi","raw_affiliation_strings":["Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Respirology, Graduate School of Medicine, Chiba University, Chiba, Japan","institution_ids":["https://openalex.org/I159385669"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061343194","display_name":"Hideaki Shimada","orcid":"https://orcid.org/0000-0002-1990-8217","observed_orcids":["https://orcid.org/0000-0002-1990-8217"]},"institutions":[{"id":"https://openalex.org/I129634264","display_name":"Toho University","ror":"https://ror.org/02hcx7n63","country_code":"JP","type":"education","lineage":["https://openalex.org/I129634264"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideaki Shimada","raw_affiliation_strings":["Department of Surgery, School of Medicine, Toho University, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Surgery, School of Medicine, Toho University, Tokyo, Japan","institution_ids":["https://openalex.org/I129634264"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003021107","display_name":"Kenzo Hiroshima","orcid":"https://orcid.org/0000-0002-0865-0820","observed_orcids":["https://orcid.org/0000-0002-0865-0820"]},"institutions":[{"id":"https://openalex.org/I4387152931","display_name":"Tokyo Women's Medical University Yachiyo Medical Center","ror":"https://ror.org/038s3xg41","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4387152931"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kenzo Hiroshima","raw_affiliation_strings":["Department of Pathology, Tokyo Women\u2019s Medical University Yachiyo Medical Center, Yachiyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Tokyo Women\u2019s Medical University Yachiyo Medical Center, Yachiyo, Japan","institution_ids":["https://openalex.org/I4387152931"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101754969","display_name":"Masatoshi Tagawa","orcid":"https://orcid.org/0000-0003-2906-1555","observed_orcids":["https://orcid.org/0000-0003-2906-1555"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]},{"id":"https://openalex.org/I4405286631","display_name":"Chiba Cancer Center Research Institute","ror":"https://ror.org/02p9eh956","country_code":"JP","type":"facility","lineage":["https://openalex.org/I4210115246","https://openalex.org/I4405286631"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Masatoshi Tagawa","raw_affiliation_strings":["Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan","Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular Biology and Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan","institution_ids":["https://openalex.org/I159385669"]},{"raw_affiliation_string":"Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, Chiba, Japan","institution_ids":["https://openalex.org/I4405286631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5101754969"],"corresponding_institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4405286631"],"apc_list":{"value":2382,"currency":"USD","value_usd":2382},"apc_paid":{"value":2382,"currency":"USD","value_usd":2382},"fwci":0.46,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.68699073,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"8","issue":"8","first_page":"e72709","last_page":"e72709"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":0.9448000192642212,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11026","display_name":"Occupational and environmental lung diseases","score":0.9448000192642212,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11668","display_name":"interferon and immune responses","score":0.04340000078082085,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/interferon-beta","display_name":"interferon-beta","score":0.9599999785423279},{"id":"https://openalex.org/keywords/mesothelioma","display_name":"mesothelioma","score":0.9620000123977661},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.9089999794960022},{"id":"https://openalex.org/keywords/pemetrexed","display_name":"pemetrexed","score":1.0},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7860000133514404},{"id":"https://openalex.org/keywords/synergistic-antitumor-effect","display_name":"synergistic antitumor effect","score":0.8169999718666077},{"id":"https://openalex.org/keywords/type-i-interferon","display_name":"type I interferon","score":0.9049999713897705},{"id":"https://openalex.org/keywords/interferon-lambda","display_name":"interferon lambda","score":0.9160000085830688},{"id":"https://openalex.org/keywords/p53-phosphorylation","display_name":"p53 phosphorylation","score":0.753000020980835},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8479999899864197},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.9049999713897705},{"id":"https://openalex.org/keywords/mhc-class-i-antigen-expression","display_name":"MHC class I antigen expression","score":0.8130000233650208},{"id":"https://openalex.org/keywords/interferon-alpha","display_name":"interferon-alpha","score":0.6100000143051147}],"concepts":[{"id":"https://openalex.org/C2777240266","wikidata":"https://www.wikidata.org/wiki/Q415220","display_name":"Pemetrexed","level":4,"score":0.8642284870147705},{"id":"https://openalex.org/C2777407522","wikidata":"https://www.wikidata.org/wiki/Q1077603","display_name":"Mesothelioma","level":2,"score":0.8094241619110107},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.7207722663879395},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.6303467750549316},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6218984127044678},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5083433985710144},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.49154147505760193},{"id":"https://openalex.org/C2776178377","wikidata":"https://www.wikidata.org/wiki/Q188269","display_name":"Interferon","level":2,"score":0.47587719559669495},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.47184184193611145},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.41137874126434326},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3413461744785309},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3229837715625763},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2336498200893402},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17883333563804626},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10957181453704834},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10063880681991577},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.057012736797332764}],"mesh":[{"descriptor_ui":"D000068437","descriptor_name":"Pemetrexed","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005971","descriptor_name":"Glutamates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D005971","descriptor_name":"Glutamates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006147","descriptor_name":"Guanine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008654","descriptor_name":"Mesothelioma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008654","descriptor_name":"Mesothelioma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016159","descriptor_name":"Tumor Suppressor Protein p53","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D016899","descriptor_name":"Interferon-beta","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017471","descriptor_name":"Receptors, Interferon","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":7,"locations":[{"id":"doi:10.1371/journal.pone.0072709","doi":"https://doi.org/10.1371/journal.pone.0072709","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0072709","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0072709&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2741224","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3745385","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:23977343","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23977343","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PloS one","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3745385","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3745385/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS One","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:943fe8434e154e2ca5ab8636b9f71caf","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/943fe8434e154e2ca5ab8636b9f71caf","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"PLoS ONE, Vol 8, Iss 8, p e72709 (2013)","raw_type":"article"},{"id":"pmh:oai:figshare.com:article/775227","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/_Interferon_946_Produces_Synergistic_Combinatory_Anti_Tumor_Effects_with_Cisplatin_or_Pemetrexed_on_Mesothelioma_Cells_/775227","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.792.5795","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.792.5795","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/f9/e2/pone.0072709.PMC3745385.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.1371/journal.pone.0072709","doi":"https://doi.org/10.1371/journal.pone.0072709","is_oa":true,"landing_page_url":"https://doi.org/10.1371/journal.pone.0072709","pdf_url":"https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0072709&type=printable","source":{"id":"https://openalex.org/S202381698","display_name":"PLoS ONE","issn_l":"1932-6203","issn":["1932-6203"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315706","host_organization_name":"Public Library of Science","host_organization_lineage":["https://openalex.org/P4310315706"],"host_organization_lineage_names":["Public Library of Science"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"PLoS ONE","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9763000011444092}],"study_designs":[],"awards":[{"id":"https://openalex.org/G103142345","display_name":"A novel therapy for lung cancer targeting cancer stem cells.","funder_award_id":"23591136","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"},{"id":"https://openalex.org/G2695090860","display_name":"Activation of the p53 pathway by gene medicine and a chemotherapeutic agent produces anti-tumor effects on human mesothelioma cells","funder_award_id":"24591185","funder_id":"https://openalex.org/F4320334764","funder_display_name":"Japan Society for the Promotion of Science"}],"funders":[{"id":"https://openalex.org/F4320320912","display_name":"Ministry of Education, Culture, Sports, Science and Technology","ror":"https://ror.org/048rj2z13"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2053481663.pdf","grobid_xml":"https://content.openalex.org/works/W2053481663.grobid-xml"},"referenced_works_count":28,"referenced_works":["https://openalex.org/W1974265455","https://openalex.org/W1974313884","https://openalex.org/W1974471239","https://openalex.org/W1975923823","https://openalex.org/W1984264526","https://openalex.org/W1984968306","https://openalex.org/W1996318954","https://openalex.org/W1998032247","https://openalex.org/W2004224840","https://openalex.org/W2005349575","https://openalex.org/W2022399395","https://openalex.org/W2031423498","https://openalex.org/W2044183610","https://openalex.org/W2046598720","https://openalex.org/W2054673942","https://openalex.org/W2064074167","https://openalex.org/W2084540550","https://openalex.org/W2086164999","https://openalex.org/W2091256596","https://openalex.org/W2102627969","https://openalex.org/W2109199074","https://openalex.org/W2110809498","https://openalex.org/W2119885778","https://openalex.org/W2127587768","https://openalex.org/W2130276477","https://openalex.org/W2266560927","https://openalex.org/W2318313893","https://openalex.org/W4211134618"],"related_works":["https://openalex.org/W2091264604","https://openalex.org/W2063744642","https://openalex.org/W2096819339","https://openalex.org/W2023550001","https://openalex.org/W2333065469","https://openalex.org/W2086821422","https://openalex.org/W2007481869","https://openalex.org/W1985430354","https://openalex.org/W2062882813"],"abstract_inverted_index":{"Interferons":[0],"(IFNs)":[1],"have":[2],"been":[3],"tested":[4],"for":[5,175],"the":[6,17,21,71,83,150,170],"therapeutic":[7],"effects":[8,19,201],"in":[9,140],"various":[10],"types":[11],"of":[12,16,42,51,82,160,167],"malignancy,":[13],"but":[14,65],"mechanisms":[15],"anti-tumors":[18],"and":[20,45,59,78,108,111,127,149,153,162],"differential":[22],"biological":[23,136],"activities":[24,41,77,137],"among":[25],"IFN":[26],"members":[27],"are":[28,169],"dependent":[29],"on":[30,48,206],"respective":[31],"cell":[32,72,116],"types.":[33],"In":[34],"this":[35],"study,":[36],"we":[37],"examined":[38],"growth":[39,75],"inhibitory":[40,76],"type":[43,62,67,103],"I":[44,63,88,104,143],"III":[46,68],"IFNs":[47,64,69,105],"5":[49],"kinds":[50],"human":[52],"mesothelioma":[53,207],"cells":[54,145],"bearing":[55],"wild-type":[56],"p53":[57,147,210],"gene,":[58],"showed":[60,131],"that":[61,102,132,196],"not":[66],"decreased":[70],"viabilities.":[73],"Moreover,":[74],"up-regulated":[79,209],"expression":[80,148],"levels":[81],"major":[84],"histocompatibility":[85],"complexes":[86],"class":[87],"antigens":[89],"were":[90,119,182],"greater":[91,121],"with":[92,95,122,202],"IFN-\u03b2":[93,123,133,161,197],"than":[94,124,138],"IFN-\u03b1":[96,125,139],"treatments.":[97],"Cell":[98],"cycle":[99,117],"analyses":[100],"demonstrated":[101,191],"increased":[106,146,186],"S-":[107],"G2/M-phase":[109],"populations,":[110],"subsequently":[112],"sub-G1-phase":[113,187],"fractions.":[114,188],"The":[115],"changes":[118],"also":[120,183],"treatments,":[126],"these":[128],"data":[129,190],"collectively":[130],"had":[134],"stronger":[135],"mesothelioma.":[141],"Type":[142],"IFNs-treated":[144],"phosphorylation":[151],"levels,":[152],"activated":[154],"apoptotic":[155],"pathways.":[156],"A":[157],"combinatory":[158],"use":[159],"cisplatin":[163,203],"or":[164,204],"pemetrexed,":[165],"both":[166],"which":[168,181],"current":[171],"first-line":[172],"chemotherapeutic":[173],"agents":[174],"mesothelioma,":[176],"produced":[177,198],"synergistic":[178,199],"anti-tumor":[179,200],"effects,":[180],"evidenced":[184],"by":[185],"These":[189],"firstly":[192],"to":[193],"our":[194],"knowledge":[195],"pemetrexed":[205],"through":[208],"expression.":[211]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2053481663","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
